Volume 101, Issue 3 pp. 536-542
ORIGINAL ARTICLE - CLINICAL SCIENCE

Validation of the new PROGRESS-CTO complication risk scores in the OPEN-CTO registry

Lorenzo Azzalini MD, PhD, MSc

Corresponding Author

Lorenzo Azzalini MD, PhD, MSc

Department of Medicine, Division of Cardiology, University of Washington, Seattle, Washington, USA

Correspondence Lorenzo Azzalini, MD, PhD, MSc, Department of Medicine, Division of Cardiology, University of Washington Medical Center, 1959 NE Pacific St, Box 356422, Seattle, WA 98195, USA. 

Email: [email protected]

Search for more papers by this author
Taishi Hirai MD

Taishi Hirai MD

Department of Medicine, Division of Cardiology, University of Missouri, Columbia, Missouri, USA

Search for more papers by this author
Adam Salisbury MD, MSc

Adam Salisbury MD, MSc

Saint Luke's Mid America Heart Institute, Kansas City, Missouri, USA

Search for more papers by this author
Kensey Gosch MS

Kensey Gosch MS

Saint Luke's Mid America Heart Institute, Kansas City, Missouri, USA

Search for more papers by this author
James Sapontis MBBCh

James Sapontis MBBCh

Monash Heart, Monash University, Melbourne, Australia

Search for more papers by this author
William J. Nicholson MD

William J. Nicholson MD

Department of Medicine, Division of Cardiology, Emory University, Atlanta, Georgia, USA

Search for more papers by this author
Dimitri Karmpaliotis MD, PhD

Dimitri Karmpaliotis MD, PhD

Gagnon Cardiovascular Institute, Morristown Medical Center, Morristown, New Jersey, USA

Search for more papers by this author
Jeffrey W. Moses MD

Jeffrey W. Moses MD

New York Presbyterian Hospital, Columbia University, New York, New York, USA

St. Francis Hospital & Heart Center, Roslyn, New York, USA

Search for more papers by this author
Kathleen E. Kearney MD

Kathleen E. Kearney MD

Department of Medicine, Division of Cardiology, University of Washington, Seattle, Washington, USA

Search for more papers by this author
William L. Lombardi MD

William L. Lombardi MD

Department of Medicine, Division of Cardiology, University of Washington, Seattle, Washington, USA

Search for more papers by this author
James Aaron Grantham MD

James Aaron Grantham MD

Saint Luke's Mid America Heart Institute, Kansas City, Missouri, USA

Search for more papers by this author
First published: 22 January 2023
Citations: 1

Abstract

Background

Risk stratification before chronic total occlusion (CTO) percutaneous coronary intervention (PCI) is important to inform procedural planning as well as patients and their families. We sought to externally validate the PROGRESS-CTO complication risk scores in the OPEN-CTO registry.

Methods

OPEN-CTO is a prospective registry of 1000 consecutive CTO PCIs performed at 12 experienced US centers using the hybrid algorithm. Endpoints of interest were in-hospital all-cause mortality, need for pericardiocentesis, acute myocardial infarction (MI), and major adverse cardiovascular events (MACE) (a composite of all-cause mortality, stroke, periprocedural MI, urgent repeat revascularization, and tamponade requiring pericardiocentesis). Model discrimination was assessed with the area under the curve (AUC) method, and calibration with the observed-versus-predicted probability method.

Results

Mean age was 65.4 ± 10.3 year, and 36.5% of patients had prior coronary artery bypass graft. Overall, 41 patients (4.1%) suffered MACE, 9 (0.9%) mortality, 26 (2.6%) acute MI, and 11 (1.1%) required pericardiocentesis. Technical success was achieved in 86.3%. Patients who experienced MACE had higher anatomic complexity, and more often required antegrade dissection/reentry and the retrograde approach. Increasing PROGRESS-CTO MACE scores were associated with increasing MACE rates: 0.5% (score 0−1), 2.4% (score 2), 3.7% (score 3), 4.5% (score 4), 7.8% (score 5), 13.0% (score 6−7). The AUC were as follows: MACE 0.72 (95% confidence interval [CI]: 0.66−0.78), mortality 0.79 (95% CI: 0.66−0.95), pericardiocentesis 0.71 (95% CI: 0.60−0.82), and acute MI 0.57 (95% CI: 0.49−0.66). Calibration was adequate for MACE and mortality, while the models underestimated the risk of pericardiocentesis and acute MI.

Conclusions

In a large external cohort of patients treated with the hybrid algorithm by experienced CTO operators, the PROGRESS-CTO MACE, mortality, and pericardiocentesis risk scores showed good discrimination, while the acute MI score had inferior performance.

DATA AVAILABILITY STATEMENT

Research data are not shared.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.